"Chemokines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Class of pro-inflammatory cytokines that have the ability to attract and activate leukocytes. They can be divided into at least three structural branches: C; (CHEMOKINES, C); CC; (CHEMOKINES, CC); and CXC; (CHEMOKINES, CXC); according to variations in a shared cysteine motif.
| Descriptor ID |
D018925
|
| MeSH Number(s) |
D12.644.276.374.200 D12.776.467.374.200 D23.125.300 D23.469.200 D23.529.374.200
|
| Concept/Terms |
Chemokines- Chemokines
- Cytokines, Chemotactic
- Intercrines
- Chemotactic Cytokines
|
Below are MeSH descriptors whose meaning is more general than "Chemokines".
Below are MeSH descriptors whose meaning is more specific than "Chemokines".
This graph shows the total number of publications written about "Chemokines" by people in this website by year, and whether "Chemokines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 2 | 2 |
| 2005 | 2 | 1 | 3 |
| 2006 | 1 | 0 | 1 |
| 2007 | 3 | 2 | 5 |
| 2008 | 1 | 1 | 2 |
| 2009 | 1 | 1 | 2 |
| 2010 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 1 | 1 | 2 |
| 2014 | 0 | 1 | 1 |
| 2015 | 2 | 1 | 3 |
| 2016 | 1 | 1 | 2 |
| 2017 | 9 | 41 | 50 |
| 2018 | 10 | 33 | 43 |
| 2019 | 4 | 5 | 9 |
| 2020 | 11 | 13 | 24 |
| 2021 | 5 | 12 | 17 |
| 2022 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Chemokines" by people in Profiles.
-
Differential Cytokine Signatures of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Influenza Infection Highlight Key Differences in Pathobiology. Clin Infect Dis. 2022 01 29; 74(2):254-262.
-
Type I, II, and III Interferon Signatures Correspond to Coronavirus Disease 2019 Severity. J Infect Dis. 2021 09 01; 224(5):777-782.
-
Immunometabolic signatures predict risk of progression to sepsis in COVID-19. PLoS One. 2021; 16(8):e0256784.
-
Matrix metalloproteinases are involved in the development of neurological complications in patients with Coronavirus disease 2019. Int Immunopharmacol. 2021 Nov; 100:108076.
-
Distinct Cytokine and Chemokine Dysregulation in Hospitalized Children With Acute Coronavirus Disease 2019 and Multisystem Inflammatory Syndrome With Similar Levels of Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 Shedding. J Infect Dis. 2021 08 16; 224(4):606-615.
-
COVID-19, Ebola virus disease, and Nipah virus infection reclassification as novel acute immune dysrhythmia syndrome (n-AIDS): potential crucial role for immunomodulators. Immunol Res. 2021 10; 69(5):457-460.
-
Associations of immunological features with COVID-19 severity: a systematic review and meta-analysis. BMC Infect Dis. 2021 Aug 03; 21(1):738.
-
High-dose intravenous immunoglobulins might modulate inflammation in COVID-19 patients. Life Sci Alliance. 2021 09; 4(9).
-
Immediate Pre-Partum SARS-CoV-2 Status and Immune Profiling of Breastmilk: A Case-Control Study. Front Immunol. 2021; 12:720716.
-
Cerebrospinal fluid cytokine, chemokine, and SARS-CoV-2 antibody profiles in children with neuropsychiatric symptoms associated with COVID-19. Mult Scler Relat Disord. 2021 Oct; 55:103169.